• Study of Venetoclax in Chronic Myeloid Leukemia Patients After Stopping Tyrosine Kinase Inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria

  • Study on Azithromycin for Treating Chronic Sinusitis in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Poland Spain

  • Study on Metyrapone for Patients with Mild Autonomous Cortisol Secretion Due to Adrenal Adenoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria

  • Study on the Effectiveness of Vidofludimus Calcium (IMU-838) in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Germany Lithuania Poland

  • Study Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Germany The Netherlands

  • Study on the Effects of Botulinum Toxin Type A for Treating Moderate to Severe Forehead Lines in Adults

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Germany

  • Study comparing trifluridine/tipiracil with bevacizumab versus capecitabine with bevacizumab as first-line treatment for patients with metastatic colorectal cancer who cannot receive intensive therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Poland Slovakia Sweden

  • Study of Mirvetuximab Soravtansine compared to standard chemotherapy in women with platinum-resistant advanced ovarian cancer with high folate receptor expression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by